What are rare genetic diseases?

More than 7,000 conditions are classified as rare, and most have a genetic origin. Each is uncommon on its own, yet together they affect thousands of Malaysian families - many waiting years for a diagnosis.

What are WES and WGS screening?

Whole Exome Sequencing (WES) reads the protein-coding regions of DNA to target identified variants efficiently, while Whole Genome Sequencing (WGS) maps the complete genome to uncover complex genetic markers. We arrange seamless sample logistics to leading local and international labs.

How can hospitals access therapies not yet registered in Malaysia?

Through named-patient supply and compassionate use programs. We facilitate NPRA registration and MOH special import permits, so clinicians can bring the right therapy to the right patient with confidence.

How is patient genomic data protected?

All patient genomic data is handled under strict PDPA and GDPR standards. Privacy and security are built into every step of our diagnostics workflow, from sample collection to result delivery.

How are temperature-sensitive therapies delivered?

Our GDP-certified cold chain includes ultra-low temperature infrastructure down to -80 degrees Celsius and cryo-preservation, with secure, temperature-monitored transit to hospitals and clinics across Peninsular and East Malaysia.

Rare Genetic Disease Specialists

Bridging the Gap from Genomic Insights to Curative Therapies.

Malaysia’s trusted end-to-end partner in rare genetic disease diagnostics, specialized logistics, and advanced therapeutics.

Partner With Us Explore Our Services

Genomic Diagnostics

Answers sooner — high-precision WES and WGS screening for Malaysian families.

Specialized Bio-Logistics

Cold-chain infrastructure down to −80°C, protecting every high-value therapy.

Market Access

Regulatory navigation that brings international innovations to Malaysian clinicians.

Orphan Access - supporting Malaysian families with rare genetic diseases

100% Dedicated to Rare Diseases

Why Orphan Access

One Partner From First Screening To Final Delivery

Rare diseases are individually rare — but together they affect thousands of Malaysian families, many still waiting for answers. Orphan Access closes that gap as one specialized partner, connecting world-class genomic insights to the life-changing therapies that follow.

For Clinicians & Hospitals

A single point of contact — from genomic screening and import permits to bedside delivery of advanced therapeutics.
For Patients & Families

A shorter diagnostic odyssey, and access to treatments that were once out of reach in Malaysia.

More About Us

Our Services

From Diagnosis to Delivery, One Seamless Ecosystem

Every step between a family’s first genetic test and a delivered therapy is handled by one accountable team — compliant, monitored, and built for rare disease care.

Advanced genomic diagnostics - WES and WGS screening

For Clinicians & Partners

Bring a Therapy to Your Patient

Named-patient and compassionate use supply for therapies not yet registered locally
NPRA registration and MOH special import permits handled end-to-end
GDP-certified, temperature-monitored delivery to your hospital or clinic

Partner With Us

Ready to Partner With Us?

From genomic insights to curative therapies — let’s build access together for every Malaysian patient.

Partner With Us

Rare Genetic Disease Specialists

Bridging the Gap from Genomic Insights to Curative Therapies.

Genomic Diagnostics

Specialized Bio-Logistics

Market Access

100% Dedicated to Rare Diseases

One Partner From First Screening To Final Delivery

For Clinicians & Hospitals

For Patients & Families

From Diagnosis to Delivery, One Seamless Ecosystem

Advanced Genomic Diagnostics

Specialized Bio-Logistics

Market Access & Regulatory Support

Bring a Therapy to Your Patient

Ready to Partner With Us?